Document is current
Any future updates will be listed below
-
Authors
Piroth, M. D. https://orcid.org/0000-0002-6934-4624
Krug, D.
Baumann, R.
Strnad, V.
Borm, K.
Combs, S.
Corradini, S.
Duma, M. N.
Dunst, J.
Fastner, G.
Feyer, P.
Fietkau, R.
Harms, W.
Hehr, T.
Hörner-Rieber, J.
Matuschek, C.
Schmeel, C.
Budach, W.
,
-
Funding
Funding for this research was provided by:
Private Universität Witten/Herdecke gGmbH
- License Information
-
More Information
Article History
Received: 1 November 2024
Accepted: 10 November 2024
First Online: 9 January 2025
Conflict of interest
: D. Krug has received honoraria from Astra Zeneca, best practice onkologie, ESO, ESMO, Gilead, med update, Merck Sharp & Dohme, Novartis, onkowissen, and Pfizer as well as research funding from the Stiftung Deutsche Krebshilfe and Merck KGaA. K. Borm has received Speaker Honoraria from Accuray and Travel Grant from Carl Zeiss. J. Hörner-Rieber reports honoraria and travel reimbursement by Viewray Inc., Pfizer Inc, Sanofi, and AstraZeneca as well as research grants from IntraOP Medical and Varian Medical Systems outside the submitted work. C. Matuschek has received research funding from the Stiftung Deutsche Krebshilfe. M.D. Piroth, R. Baumann, V. Strnad, S. Combs, S. Corradini, M.N. Duma, J. Dunst, G. Fastner, P. Feyer, R. Fietkau, W. Harms, T. Hehr, C. Schmeel, and W. Budach declare that they have no competing interests.
